Gelteq GELS
NASDAQ GELS
$0.57 +0.01 (+1.65%)
As of: Aug 21, 2026 · 11:54 AM EDT

Gelteq (GELS) Receivables - Other (2023 - 2025)

Gelteq (GELS) posted quarterly Receivables - Other of $259702.5 for Q4 2025, up 30.2% year-over-year from $199461.3 in Q4 2024, and up 3.76% quarter-over-quarter from $250281.3 in Q2 2025.

Gelteq (GELS) Receivables - Other (2023 - 2025) Analysis & Trends

Gelteq's Receivables - Other history runs 3 years deep, the most recent figure standing at $259702.5 for Q4 2025.

  • In Q4 2025, Receivables - Other rose 30.2% year-over-year to $259702.5; the TTM figure through Dec 2025 stood at $259702.5 (up 30.2% YoY), while the FY2025 annual figure was $250281.3, up 165.0% from the prior year.
  • Receivables - Other for Q4 2025 stood at $259702.5, up from $250281.3 in the prior quarter.
  • The five-year high for Receivables - Other was $259702.5 in Q4 2025, with the low at $94446.8 in Q2 2024.
  • The 3-year median for Receivables - Other is $199461.3 (2024), against an average of $195941.8.
  • The sharpest annual moves came in 2024 and 2025: Receivables - Other tumbled 46.28% in 2024, then soared 165.0% in 2025.
  • Gelteq's Receivables - Other stood at $175816.9 in 2023, then gained by 13.45% to $199461.3 in 2024, then surged by 30.2% to $259702.5 in 2025.
  • Business Quant data shows GELS's Receivables - Other at $259702.5 in Q4 2025, $250281.3 in Q2 2025, and $199461.3 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.42 Bn 43.46 Bn -
2 Teva Pharmaceutical Industries 43.71 Bn 40.06 Bn 2.15 Bn
3 Zoetis 32.56 Bn 30.88 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.84 Bn 5.10 Bn
5 United Therapeutics 22.08 Bn 19.41 Bn 683.80 Mn
6 Viatris 18.92 Bn 18.03 Bn 1.46 Bn
7 Neurocrine Biosciences 15.48 Bn 15.09 Bn 935.80 Mn
8 Elanco Animal Health 11.99 Bn 11.46 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.15 Bn 9.99 Bn -
10 Gelteq 5.94 Mn 5.67 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 259,702.54
Dec 31, 2025 259,702.54
Jun 30, 2025 250,281.30
Jun 30, 2025 250,281.30
Dec 31, 2024 199,461.34
Dec 31, 2024 199,461.34
Jun 30, 2024 94,446.78
Jun 30, 2024 94,446.78
Jun 30, 2023 175,816.89
Jun 30, 2023 175,816.89